| UniProt ID | T2EB_MOUSE | |
|---|---|---|
| UniProt AC | Q9D902 | |
| Protein Name | General transcription factor IIE subunit 2 | |
| Gene Name | Gtf2e2 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 292 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Recruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase (By similarity).. | |
| Protein Sequence | MDPSLLRDRELFKKRALSTPVVEKRAVPSESPSSSSSKKKKAKVEHGGSSGSKQNSDHNNGSFNLKALSGSSGYKFGVLAKIVNYMKTRHQRGDTHPLTLEEILDETQHLDIGLKQKQWLMTEALVNNPKIEVVDGKYAFKPKYNLKDKKALLRLLDNHDQRGLGGILLEDIEEGLPNSQKAVKALGDQILFVSRPDKKKILFFNDKSCQFSVDEEFQKLWRSVTVDSMDEEKIEEYLKRQGISSMQESGPKKVASIQRRKKPASQKKRRFKTHNEHLAGVLKDYSDITPGK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDPSLLRD -------CCHHHHHC | 18.04 | - | |
| 18 | Phosphorylation | LFKKRALSTPVVEKR HHHHHCCCCCEECCC | 29.67 | 26824392 | |
| 19 | Phosphorylation | FKKRALSTPVVEKRA HHHHCCCCCEECCCC | 22.43 | 28066266 | |
| 29 | Phosphorylation | VEKRAVPSESPSSSS ECCCCCCCCCCCCCC | 44.07 | 23984901 | |
| 31 | Phosphorylation | KRAVPSESPSSSSSK CCCCCCCCCCCCCCC | 34.13 | 26824392 | |
| 33 | Phosphorylation | AVPSESPSSSSSKKK CCCCCCCCCCCCCHH | 52.73 | 25266776 | |
| 34 | Phosphorylation | VPSESPSSSSSKKKK CCCCCCCCCCCCHHH | 37.31 | 23984901 | |
| 35 | Phosphorylation | PSESPSSSSSKKKKA CCCCCCCCCCCHHHC | 42.86 | 28066266 | |
| 36 | Phosphorylation | SESPSSSSSKKKKAK CCCCCCCCCCHHHCC | 48.39 | 23984901 | |
| 37 | Phosphorylation | ESPSSSSSKKKKAKV CCCCCCCCCHHHCCC | 50.90 | 27149854 | |
| 62 | Phosphorylation | NSDHNNGSFNLKALS CCCCCCCCEEEEEEC | 17.06 | - | |
| 72 | Phosphorylation | LKALSGSSGYKFGVL EEEECCCCCCHHHHH | 50.06 | 27149854 | |
| 75 | Acetylation | LSGSSGYKFGVLAKI ECCCCCCHHHHHHHH | 38.88 | 23806337 | |
| 115 | Ubiquitination | QHLDIGLKQKQWLMT CCCCCCHHHHHHHHH | 50.68 | - | |
| 181 | Ubiquitination | EGLPNSQKAVKALGD HCCCCCHHHHHHHCC | 55.77 | - | |
| 256 | Phosphorylation | SGPKKVASIQRRKKP HCHHHHHHHHHCCCC | 23.42 | 24719451 | |
| 286 | Phosphorylation | AGVLKDYSDITPGK- HHHHCCHHCCCCCC- | 32.44 | 26745281 | |
| 289 | Phosphorylation | LKDYSDITPGK---- HCCHHCCCCCC---- | 30.86 | 22006019 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of T2EB_MOUSE !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of T2EB_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of T2EB_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| T2EA_MOUSE | Gtf2e1 | physical | 20211142 | |
| TADBP_MOUSE | Tardbp | physical | 20211142 | |
| T2EA_HUMAN | GTF2E1 | physical | 26496610 | |
| TAU_HUMAN | MAPT | physical | 26496610 | |
| 2AAA_HUMAN | PPP2R1A | physical | 26496610 | |
| 2A5E_HUMAN | PPP2R5E | physical | 26496610 | |
| TICN1_HUMAN | SPOCK1 | physical | 26496610 | |
| SPT6H_HUMAN | SUPT6H | physical | 26496610 | |
| ABI1_HUMAN | ABI1 | physical | 26496610 | |
| WASF2_HUMAN | WASF2 | physical | 26496610 | |
| CASC3_HUMAN | CASC3 | physical | 26496610 | |
| CYFP1_HUMAN | CYFIP1 | physical | 26496610 | |
| NHSL1_HUMAN | NHSL1 | physical | 26496610 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...